{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:52:08Z","timestamp":1768639928805,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Amsterdam Medical Center Innovation grant"},{"name":"FP7 Health. To the Euro-TEAM consortium.","award":["305549"],"award-info":[{"award-number":["305549"]}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["91718371"],"award-info":[{"award-number":["91718371"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amsterdam Medical Center fellowship grant"},{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","award":["16-1-302"],"award-info":[{"award-number":["16-1-302"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Analyses of lymphoid organs are required to further elucidate the pathogenesis of inflammatory diseases like rheumatoid arthritis (RA). Yet, invasive tissue collection methods are scarcely applied, because they are often considered burdensome, although patients do not always consider invasive methods as a high burden. We aimed to investigate the perspectives of study participants undergoing ultrasound-guided inguinal\u00a0lymph node (LN) needle biopsy sampling and determine the molecular and cellular quantity and quality of LN biopsies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Together with patient research partners, questionnaires were developed to evaluate the motives, expectations, and experiences of participants undergoing a LN biopsy. Healthy controls and RA(-risk) patients were asked to complete these questionnaires before and after the procedure. RNA and lymphocyte yields from obtained LN biopsies were also calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 50 individuals, of which 43 (86%) reported their pre- and post-procedure experiences. The median reported pain on a 5-point Likert scale (1 not to 5 very painful) was 1. Interestingly, almost all (<jats:italic>n<\/jats:italic> = 32; 74%) study participants would undergo a second procedure and more than half (<jats:italic>n<\/jats:italic> = 23; 54%) would encourage others to take part in the LN biopsy study. Motives for current and future participation were mostly altruistic. Inguinal hematoma occurred frequently, but no other significant or unexpected complications ensued. The LN biopsies yielded sufficient and high-quality RNA and lymphocyte numbers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Ultrasound-guided inguinal LN biopsy sampling is well-tolerated, safe, and provides sufficient material for further molecular and cellular analyses. Our participants\u2019 positive experiences endorse the application of this research tool to further elucidate the pathogenesis of RA and other inflammatory diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02728-7","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T10:03:12Z","timestamp":1643882592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ultrasound-guided lymph node biopsy sampling to study the immunopathogenesis of rheumatoid arthritis: a well-tolerated valuable research tool"],"prefix":"10.1186","volume":"24","author":[{"given":"Ren\u00e9e H.","family":"Fiechter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne W.","family":"Bolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen G. H.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B. M.","family":"Landew\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander W.","family":"Tas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa G. M.","family":"van Baarsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"issue":"6","key":"2728_CR1","doi-asserted-by":"publisher","first-page":"S685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):S685\u201399. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655.","journal-title":"Ann Rheum Dis."},{"issue":"9746","key":"2728_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094\u2013108. https:\/\/doi.org\/10.1016\/S0140-6736(10)60826-4.","journal-title":"Lancet."},{"issue":"5","key":"2728_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","volume":"71","author":"DM Gerlag","year":"2012","unstructured":"Gerlag DM, Raza K, Van Baarsen LGM, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis. 2012;71(5):638\u201341. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200990.","journal-title":"Ann Rheum Dis."},{"key":"2728_CR4","doi-asserted-by":"publisher","unstructured":"Mankia K, Siddle HJ, Kerschbaumer A, et al. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Ann Rheum Dis. 2021;1-13. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220884.","DOI":"10.1136\/annrheumdis-2021-220884"},{"issue":"October 2017","key":"2728_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cellimm.2018.01.010","volume":"330","author":"A Bellomo","year":"2018","unstructured":"Bellomo A, Gentek R, Baj\u00e9noff M, Baratin M. Lymph node macrophages: scavengers, immune sentinels and trophic effectors. Cell Immunol. 2018;330(October 2017):168\u201374. https:\/\/doi.org\/10.1016\/j.cellimm.2018.01.010.","journal-title":"Cell Immunol."},{"issue":"2","key":"2728_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen MMJ, Van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380\u20136. https:\/\/doi.org\/10.1002\/art.20018.","journal-title":"Arthritis Rheum."},{"issue":"12","key":"2728_CR7","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/eji.201646393","volume":"46","author":"TH Ramwadhdoebe","year":"2016","unstructured":"Ramwadhdoebe TH, H\u00e4hnlein J, Maijer KI, et al. Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at-risk phase of autoantibody positive rheumatoid arthritis. Eur J Immunol. 2016;46(12):2812\u201321. https:\/\/doi.org\/10.1002\/eji.201646393.","journal-title":"Eur J Immunol."},{"issue":"10","key":"2728_CR8","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, De Jong BAW, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741\u20139. https:\/\/doi.org\/10.1002\/art.11223.","journal-title":"Arthritis Rheum."},{"issue":"9","key":"2728_CR9","first-page":"1282","volume":"18","author":"K Aho","year":"1991","unstructured":"Aho K, Heli\u00f6vaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol. 1991;18(9):1282\u20134.","journal-title":"J Rheumatol."},{"issue":"1","key":"2728_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02593-w","volume":"23","author":"RE Costello","year":"2021","unstructured":"Costello RE, Humphreys JH, Sergeant JC, et al. Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT). Arthritis Res Ther. 2021;23(1):1\u201311. https:\/\/doi.org\/10.1186\/s13075-021-02593-w.","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"2728_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.38273","volume":"66","author":"MJH De Hair","year":"2014","unstructured":"De Hair MJH, Van De Sande MGH, Ramwadhdoebe TH, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66(3):513\u201322. https:\/\/doi.org\/10.1002\/art.38273.","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"2728_CR12","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O","volume":"41","author":"MC Kraan","year":"1998","unstructured":"Kraan MC, Versendaal H, Jonker M, et al. A symptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 1998;41(8):1481\u20138 https:\/\/doi.org\/10.1002\/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O.","journal-title":"Arthritis Rheum."},{"key":"2728_CR13","doi-asserted-by":"publisher","unstructured":"Bevaart L, Vervoordeldonk MJ, Tak PP. Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum. 2010;62(8):2192-2205. doi:https:\/\/doi.org\/10.1002\/art.27503","DOI":"10.1002\/art.27503"},{"issue":"8","key":"2728_CR14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/annrheumdis-2012-202990","volume":"72","author":"LGM Van Baarsen","year":"2013","unstructured":"Van Baarsen LGM, De Hair MJH, Ramwadhdoebe TH, et al. The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis. Ann Rheum Dis. 2013;72(8):1420\u20134. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202990.","journal-title":"Ann Rheum Dis."},{"issue":"AUG","key":"2728_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01863","volume":"10","author":"E Karouzakis","year":"2019","unstructured":"Karouzakis E, H\u00e4hnlein J, Grasso C, et al. Molecular characterization of human lymph node stromal cells during the earliest phases of rheumatoid arthritis. Front Immunol. 2019;10(AUG):1\u201311. https:\/\/doi.org\/10.3389\/fimmu.2019.01863.","journal-title":"Front Immunol."},{"key":"2728_CR16","doi-asserted-by":"publisher","unstructured":"Ramwadhdoebe TH, Hahnlein J, Van Kuijk BJ, et al. Human lymph-node CD8+ T cells display an altered phenotype during systemic autoimmunity. Clin Transl Immunol. 2016;5(February). https:\/\/doi.org\/10.1038\/cti.2016.8.","DOI":"10.1038\/cti.2016.8"},{"issue":"6","key":"2728_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/rheumatology\/key428","volume":"58","author":"TH Ramwadhdoebe","year":"2019","unstructured":"Ramwadhdoebe TH, Van Baarsen LGM, Boumans MJH, et al. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis. Rheumatol (United Kingdom). 2019;58(6):1075\u201385. https:\/\/doi.org\/10.1093\/rheumatology\/key428.","journal-title":"Rheumatol (United Kingdom)."},{"issue":"3","key":"2728_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/BOR.0000000000000708","volume":"32","author":"HK Greenblatt","year":"2020","unstructured":"Greenblatt HK, Kim HA, Bettner LF, Deane KD. Preclinical rheumatoid arthritis and rheumatoid arthritis prevention. Curr Opin Rheumatol. 2020;32(3):289\u201396. https:\/\/doi.org\/10.1097\/BOR.0000000000000708.","journal-title":"Curr Opin Rheumatol."},{"issue":"3","key":"2728_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00330-006-0393-0","volume":"17","author":"E de Kerviler","year":"2007","unstructured":"de Kerviler E, de Bazelaire C, Mounier N, et al. Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. Eur Radiol. 2007;17(3):843\u20139. https:\/\/doi.org\/10.1007\/s00330-006-0393-0.","journal-title":"Eur Radiol."},{"issue":"12","key":"2728_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ijcm.2013.412a2001","volume":"04","author":"MJH de Hair","year":"2013","unstructured":"de Hair MJH, van de Sande MGH, Maas M, Gerlag DM, Tak PP. Experience of patients undergoing mini-arthroscopy compared to MRI in the earliest phases of arthritis. Int J Clin Med. 2013;04(12):1\u20135. https:\/\/doi.org\/10.4236\/ijcm.2013.412a2001.","journal-title":"Int J Clin Med."},{"issue":"11","key":"2728_CR21","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1136\/annrheumdis-2012-201540","volume":"71","author":"MJH De Hair","year":"2012","unstructured":"De Hair MJH, Zijlstra IJAJ, Boumans MJH, et al. Hunting for the pathogenesis of rheumatoid arthritis: Core-needle biopsy of inguinal lymph nodes as a new research tool. Ann Rheum Dis. 2012;71(11):1911\u20132. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201540.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"2728_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40900-020-0178-7","volume":"6","author":"R Birch","year":"2020","unstructured":"Birch R, Simons G, W\u00e4h\u00e4maa H, et al. Development and formative evaluation of patient research partner involvement in a multi-disciplinary European translational research project. Res Involv Engagem. 2020;6(1):1\u201314. https:\/\/doi.org\/10.1186\/s40900-020-0178-7.","journal-title":"Res Involv Engagem."},{"issue":"1","key":"2728_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-020-00357-w","volume":"21","author":"C Gerstner","year":"2020","unstructured":"Gerstner C, Turcinov S, Hensvold AH, et al. Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis. BMC Immunol. 2020;21(1):1\u201314. https:\/\/doi.org\/10.1186\/s12865-020-00357-w.","journal-title":"BMC Immunol."},{"issue":"3","key":"2728_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/annrheumdis-2013-204603","volume":"74","author":"S Kelly","year":"2015","unstructured":"Kelly S, Humby F, Filer A, et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann Rheum Dis. 2015;74(3):611\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204603.","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"2728_CR25","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458512438117","volume":"18","author":"AR Gafson","year":"2012","unstructured":"Gafson AR, Giovannoni G. Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis. Mult Scler J. 2012;18(10):1509\u201311. https:\/\/doi.org\/10.1177\/1352458512438117.","journal-title":"Mult Scler J."},{"issue":"2","key":"2728_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000368161","volume":"88","author":"C Lemech","year":"2015","unstructured":"Lemech C, Dua D, Newmark J, et al. Patients\u2019 perceptions of research biopsies in phase i oncology trials. Oncol. 2015;88(2):95\u2013102. https:\/\/doi.org\/10.1159\/000368161.","journal-title":"Oncol."},{"issue":"7","key":"2728_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdt067","volume":"24","author":"DS Seah","year":"2013","unstructured":"Seah DS, Scott SM, Najita J, et al. Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol. 2013;24(7):1853\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdt067.","journal-title":"Ann Oncol."},{"issue":"1","key":"2728_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-015-1105-3","volume":"17","author":"SY Moorcraft","year":"2016","unstructured":"Moorcraft SY, Marriott C, Peckitt C, et al. Patients\u2019 willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 2016;17(1):1\u201312. https:\/\/doi.org\/10.1186\/s13063-015-1105-3.","journal-title":"Trials."},{"issue":"5","key":"2728_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.breast.2013.03.011","volume":"22","author":"F Naim","year":"2013","unstructured":"Naim F, Ballinger R, Rombach I, et al. Patient attitudes towards undergoing additional breast biopsy for research. Breast. 2013;22(5):850\u20135. https:\/\/doi.org\/10.1016\/j.breast.2013.03.011.","journal-title":"Breast."},{"issue":"1","key":"2728_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-016-1319-x","volume":"17","author":"K Kumar","year":"2016","unstructured":"Kumar K, Peters S, Barton A. Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study. BMC Musculoskelet Disord. 2016;17(1):1\u20136. https:\/\/doi.org\/10.1186\/s12891-016-1319-x.","journal-title":"BMC Musculoskelet Disord."},{"issue":"3","key":"2728_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/acr.23841","volume":"72","author":"E Mosor","year":"2020","unstructured":"Mosor E, Stoffer-Marx M, Steiner G, et al. I would never take preventive medication! Perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis. Arthritis Care Res. 2020;72(3):360\u20138. https:\/\/doi.org\/10.1002\/acr.23841.","journal-title":"Arthritis Care Res."},{"issue":"4","key":"2728_CR32","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/hex.12376","volume":"19","author":"L Locock","year":"2016","unstructured":"Locock L, Boylan AMR. Biosamples as gifts? How participants in biobanking projects talk about donation. Heal Expect. 2016;19(4):805\u201316. https:\/\/doi.org\/10.1111\/hex.12376.","journal-title":"Heal Expect."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02728-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T10:08:54Z","timestamp":1643882934000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02728-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2728"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02728-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave written informed consent before the procedure as approved by the Medical Ethics Committee of the Academic Medical Center, Amsterdam, the Netherlands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MGHvdS received research fees from Novartis, UCB, Eli Lily, and Janssen and consulting fees\/speaker\u2019s fees from Novartis, UCB, Eli Lily, AbbVie, and MSD. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}